SPECT Systems Market Scope
Over the past couple of decades, with upsurging technological advancements in medical imaging and diagnosis has escalated the demand for highly advanced and non-invasive techniques. The SPECT (Single Photon Emission Computed Tomography) system provides extensively validated data as well as better sensitivity. In addition to this, these systems require comparatively lower cost than the PET (Positron Emission Tomography) systems. SPECT is one medical imaging solutions which are based on the tomographic reconstruction and conventional nuclear medicine imaging methods. The SPECT produced images generate functional information about patients similar. However, the higher cost compared to echocardiography, less availability compared to echo and and very limited spatial resolution of spect systems might stagnate the demand for SPECT systems across the globe.
The market study is being classified by Type (Hybrid SPECT and Standalone SPECT), by Application (Cardiology, Oncology, General imaging and Neurology) and major geographies with country level break-up.
The Players having a strong hold in the market are Siemens, Philips, GE Healthcare, Toshiba Medical Systems, and Neusoft. Research Analyst at AMA predicts that European and United States Players will contribute to the maximum growth of Global SPECT Systems market throughout the predicted period.
Siemens Healthineers (Germany), Philips Healthcare (Netherlands), GE Healthcare (United States), Toshiba Medical Systems Corporation (Japan), Neusoft Medical Systems Co., Ltd. (China), Mediso Medical Imaging Systems Ltd. (Hungary), Digirad Corporation (United States), CMR Naviscan Corporation (United States), SurgicEye GmbH (Germany) and DDD Diagnostics (Denmark) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Abbott Diagnostics, Inc. (United States) and Bio-Rad Laboratories, Inc. (United States).
AdvanceMarketAnalytics has segmented the market of Global SPECT Systems market by Type, Application and Region.
On the basis of geography, the market of SPECT Systems has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Europe region held largest market share in the year 2018. North America on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by End User, the sub-segment i.e. Hospitals will boost the SPECT Systems market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Leaders and their expansionary development strategies
On May 14, 2019, a leading global health technology company "Royal Philips", has signed a 10-year strategic partnership agreement with Rutherford Diagnostics. This collaboration will utilize Philips innovative radiology technology and Rutherford Diagnostics’ healthcare expertise to deliver and operate advanced personalized diagnostic services through a network of community diagnostic centers, driving the best possible healthcare outcomes for patients. Rutherford Diagnostics is a subsidiary of Proton Partners International which operates diagnostic and cancer centers across the United Kingdom.
On May 22, 2019, "Siemens Healthineers" has introduced its Digital Therapy Suite. The centerpiece of the Digital Therapy Suite is the new Artis icono cardiovascular edition card angiography system. The Digital Therapy Suite demonstrates how already today digitalization is able to simplify and improve procedural workflows for the full spectrum of cardiovascular interventional therapies, including coronary and structural heart interventions as well as EP procedures.
- Development of New Dedicated Cameras/Detectors for Cardiac-Specific Imaging
- Growing Adoption of New-Generation Cadmium Z0inc Telluride (CZT) Detector That Enables High-Resolution, Low-Dose Nuclear Scans
- Provides Extensively Validated Data with Better Sensitivity
- Comparatively Lower Cost of SPECT than PET (Positron Emission Tomography)
- Increasing Adoption of Combined SPECT/CT in One Imaging System Using a Single Patient Table
- Growing Adoption of Reliability, and Cost-Effective Data
- Higher Cost Compared to Echocardiography and Less Availability Compared to Echo
- Very Limited Spatial Resolution of SPECT Systems
- Potential Complexities in Interpreting and Analysing SPECT Results
- Compared to CMR and Echocardiography, SPECT has some Radiation Risks
Key Target AudienceSPECT System Manufacturers, SPECT System Distributors and Traders, Diagnostic Centers, Neurological Centers, Health Centers/Clinics, Research and Development Institutes, Government Agencies and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase